| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 296,224 | 296,342 | 295,165 | 292,237 | | Cost of Revenue | (461,553) | 186,368 | 275,185 | 230,024 | | | Gross Profit | 757,777 | 109,974 | 19,980 | 62,213 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 752,221 | 101,603 | 12,442 | 56,269 | | Non Recurring | 2,947 |
-
|
-
|
-
| | Others | 4,001 | 4,267 | 4,177 | 3,746 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,555 | 4,104 | 3,361 | 2,198 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,469 | 7,325 | 23,298 | (6,891) | | Earnings Before Interest And Taxes | 6,054 | 11,320 | 26,659 | (4,693) | | Interest Expense | 964 | 1,245 | 1,181 | 1,447 | | Income Before Tax | 5,090 | 10,075 | 25,478 | (6,140) | | Income Tax Expense | 565 | 993 | 516 | 472 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,525 | 9,082 | 24,962 | (6,612) | | | Non-recurring Events | | Discontinued Operations | (417) | (504) | 410 | (740) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,108 | 8,578 | 25,372 | (7,352) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,108 | $8,578 | $25,372 | ($7,352) |
|
0.51% Nasdaq 
Income Statement
